Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
J Immunol ; 164(6): 3123-31, 2000 Mar 15.
Artigo em Inglês | MEDLINE | ID: mdl-10706702

RESUMO

CD19 is a coreceptor on B cells that enhances the increase in cytoplasmic calcium and ERK2 activation when coligated with the B cell Ag receptor. Constructs containing point mutations and truncations were expressed in Daudi human B lymphoblastoid cells to systematically determine the requirement for individual CD19 cytoplasmic tyrosines in these responses. Evidence for activity was found for Y330, Y360, and Y421 as well as that previously published for Y391. Precipitates formed with phosphopeptides consisting of CD19 sequences flanking these residues were used to screen for cytoplasmic proteins that mediate signaling. Phosphopeptide Y330 precipitated Grb2 and Sos, whereas phosphopeptides Y391 and Y421 both precipitated Vav and phospholipase C-gamma2. These molecules also were found associated with native CD19. In mapping studies with altered constructs, CD19 Y330 and/or Y360 were necessary for binding Grb2 and Sos. Vav associated with CD19 constitutively in unstimulated cells by a tyrosine-independent mechanism requiring the portion of CD19 encoded by exons 9-12. After B cell Ag receptor stimulation, Vav association was tyrosine-dependent, but binding was influenced by multiple residues. However, when maximally phosphorylated by pervanadate, Y391 and, to a lesser extent, Y421 were sufficient. CD19 Y391 was also both necessary and sufficient for binding phospholipase C-gamma2. Thus, different tyrosines along the CD19 cytoplasmic domain provide scaffolding for the formation of complexes of different signaling molecules.


Assuntos
Proteínas Adaptadoras de Transdução de Sinal , Antígenos CD19/fisiologia , Linfócitos B/imunologia , Proteínas de Ciclo Celular , Ativação Linfocitária/imunologia , Proteínas/metabolismo , Proteínas Proto-Oncogênicas/metabolismo , Proteína Son Of Sevenless de Drosófila/metabolismo , Fosfolipases Tipo C/metabolismo , Tirosina/fisiologia , Adjuvantes Imunológicos/metabolismo , Adjuvantes Imunológicos/fisiologia , Antígenos CD19/genética , Antígenos CD19/metabolismo , Linfócitos B/efeitos dos fármacos , Linfócitos B/enzimologia , Linfócitos B/metabolismo , Sinalização do Cálcio/imunologia , Citoplasma/imunologia , Citoplasma/metabolismo , Éxons , Proteína Adaptadora GRB2 , Humanos , Isoenzimas/metabolismo , Ativação Linfocitária/efeitos dos fármacos , Sistema de Sinalização das MAP Quinases/imunologia , Proteína Quinase 1 Ativada por Mitógeno/fisiologia , Peso Molecular , Mutagênese Sítio-Dirigida , Mapeamento de Peptídeos , Fosfolipase C gama , Fosfopeptídeos/metabolismo , Proteínas Proto-Oncogênicas c-vav , Receptores de Antígenos de Linfócitos B/metabolismo , Receptores de Antígenos de Linfócitos B/fisiologia , Células Tumorais Cultivadas , Tirosina/genética , Tirosina/metabolismo , Vanadatos/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA